SciELO - Scientific Electronic Library Online

 
vol.15 issue1Usefulness of the videopupillography in the study of diabetic pupillary autonomic neuropathyResults of dacryocystorhinostomy without endocanalicular intubation with silicone author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Oftalmología

On-line version ISSN 1561-3070

Abstract

SEDENO CRUZ, Ibis; ALEMANY GONZALEZ, Jaime; CAMACHO RUAIGIP, Fariel  and  GARCIA GONZALEZ, Frank. Study of the clinical efficiency of briomonidine vs. timolol in the treatment of open-angle primary glaucoma. Rev Cubana Oftalmol [online]. 2002, vol.15, n.1, pp. 0-0. ISSN 1561-3070.

36 patients with diagnosis of open-angle primary glaucoma (OAPG) without previous treatment were studied. They were indicated timolol 0.5 % (1 drop twice a day) and after that, previous lavage with hypotensor, brimonidine 0.2 %. The intraocular pressure (IOP) and the adverse reactions were evaluated on the initial visit and on the first week, the first month and the second month. The results showed a decrease of the mean IOP compared with the initial (without treatment) with both drugs during the 2 months of treatment. A mean IOP of 17.1 mm Hg was obtained with timolol and 16.1 mm Hg with brimonidine. It represents a reduction of 7.7 mm Hg and 6.9 mm Hg, respectively. The most frequent systemic adverse reactions with the administration of brimonidine were dry mouth and headache, whereas the local adverse reactions were ocular pruritus and ocular hyperemia. The intensity of these symptoms was from mild to moderate. The study demonstrated that brimonidine has an effectiveness similar to that of timolol as regards the reduction of intraocular pressure with a good tolerability.

Keywords : GLAUCOMA; OPEN-ANGLE [drug therapy]; TREATMENT OUTCOME; TIMOLOL [therapeutic use]; TIMOLOL [adverse effects]; ADRENERGIC AGONISTS [adverse effects]; ADRENERGIC AGONISTS [therapeutic use]; INTRAOCULAR PRESSURE [drug therapy].

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License